secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2024-10-29T23:59:59+00:00
Accession:  0001493152-24-042926
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience reports FY 2024 net loss of $3.4M; product sales up 4.5% to $1.955M
--------------------------------------------------------------------------------

- Net product sales $1.955M in FY 2024 vs $1.871M in FY 2023, up $84K (4.5%).
- Net loss improved to ($3.4M) from ($3.9M); net loss per share ($0.03) vs ($0.04).
- Net cash used in operations reduced to ($2.5M) from ($3.3M).
- Shifted strategy to distribution model; partnered with multiple distributors in fiscal 2024.
- R&D focused on Clean-in-Place solutions for food processing equipment sanitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224042926/0001493152-24-042926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224042926/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer